By G HossainPosted on July 1, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Ipsen is penning its second acquisition of the week, this time securing Memo Therapeutics and its midstage monoclonal antibody in a deal that could approach $800 million. Ipsen sends clear Memo to rare diseases with up to $796M buyout Post navigation Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot programThe AI conversation the profession isn’t having